Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

CD81 is essential for the re-entry of hematopoietic stem cells to quiescence following stress-induced proliferation via deactivation of the Akt pathway.

Kuanyin K Lin | Lara Rossi | Nathan C Boles | Brian E Hall | Thaddeus C George | Margaret A Goodell
PLoS biology | 2011

The regulatory mechanisms governing the cell cycle progression of hematopoietic stem cells (HSCs) are well characterized, but those responsible for the return of proliferating HSCs to a quiescent state remain largely unknown. Here, we present evidence that CD81, a tetraspanin molecule acutely responsive to proliferative stress, is essential for the maintenance of long-term repopulating HSCs. Cd81(-/-) HSCs showed a marked engraftment defect when transplanted into secondary recipient mice and a significantly delayed return to quiescence when stimulated to proliferate with 5-fluorouracil (5FU). In addition, we found that CD81 proteins form a polarized patch when HSCs are returning to quiescence. Thus, we propose that the spatial distribution of CD81 during the HSC recovery phase drives proliferative HSC to quiescence, and is important to preserve the self-renewal properties. Here, we show that lack of CD81 leads to loss of HSC self-renewal, and the clustering of CD81 on HSC membrane results in deactivation of Akt, which subsequently leads to nuclear translocation of FoxO1a. Thus, CD81 functions as part of a previously undefined mechanism that prohibits excessive proliferation of HSCs exposed to environmental stress.

Pubmed ID: 21931533

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NHLBI NIH HHS, United States
    Id: HL08100
  • Agency: NIDDK NIH HHS, United States
    Id: DK58192
  • Agency: NIBIB NIH HHS, United States
    Id: R01 EB005173
  • Agency: NHLBI NIH HHS, United States
    Id: T32 HL092332
  • Agency: NCI NIH HHS, United States
    Id: P30 CA125123
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK058192
  • Agency: NIDDK NIH HHS, United States
    Id: T32- DK60445
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK060445
  • Agency: NIAID NIH HHS, United States
    Id: T32-AI07495
  • Agency: NIDDK NIH HHS, United States
    Id: T32-DK064717
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI007495
  • Agency: NIBIB NIH HHS, United States
    Id: EB005173
  • Agency: NCI NIH HHS, United States
    Id: P50 CA126752
  • Agency: NIDDK NIH HHS, United States
    Id: T32 DK064717
  • Agency: NCI NIH HHS, United States
    Id: P50CA126752

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions